Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

F. Hoffmann-La Roche Announces Half Year Results 2026

Дата публикации: 23-07-2026 05:00:00



Основное содержимое страницы с новостью.

Name of listed company: Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (Prime Market of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
President & CEO: Osamu Okuda
Inquiries to: Kae Miyata
Head of Corporate Communications Dept.
Tel:
For media: +81-(0)3-3273-0881
For investors: +81-(0)3-3273-0554

F. Hoffmann-La Roche Ltd. (hereafter “Roche”) [Head Office: Basel, Switzerland. CEO: Thomas Schinecker] announced today its half year results 2026 (January 1 - June 30, 2026).

Roche Holding Ltd, a parent company of Roche and Chugai, owns 59.89% of Chugai’s issued shares (61.12% of voting rights) as of June 30, 2026.

Its investor update and presentation materials can be found on its website (https://www.roche.com). Chugai’s performance for the period of January 1 to June 30, 2026 is included in the announced Roche Group’s results.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1LSR Group: LSR Group reports its operating results for the second quarter and the first half of 202604.5429-07-2026
2Cleveland-Cliffs Reports Second-Quarter 2026 Results07023-07-2026
3Cleveland-Cliffs Reports First-Quarter 2026 Results07020-04-2026
4Cleveland-Cliffs to Announce Second-Quarter 2026 Earnings Results and Host Conference Call on July 23038.5702-07-2026
5Cleveland-Cliffs to Announce First-Quarter 2026 Earnings Results and Host Conference Call on April 20038.5702-04-2026
6MHI Announces Outline of FY2026 First 3 Months Financial Results Ended June 30, 2026 (Consolidated)019.2804-08-2026
7Hogan Lovells welcomes 2026 with partner and counsel promotions across the Americas, Europe, and Asia-Pacific019.7206-01-2026
8Багаевская: День 18 дек, Вт0017-12-2018
9Багаевская: Ночь 18 дек, Вт0017-12-2018
10Дмитрий Борисов Стихи Любовь Такая разная То сладость То война ...0021-02-2025

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 35. Источник: www.chugai-pharm.co.jp.